Stay updated on Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial

Sign up to get notified when there's something new on the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added to the record history. Revision: v3.3.3 was removed.
    Difference
    0.1%
    Check dated 2026-01-14T04:20:41.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    The history now includes Revision: v3.3.3, and the HHS Vulnerability Disclosure and Revision: v3.3.2 entries were removed.
    Difference
    0.2%
    Check dated 2025-12-23T21:32:29.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The record history now includes core results-related sections such as Results Posted, Outcome Measures (Results), Adverse Events, Baseline Characteristics, and Participant Flow, along with More Information and Limitations and Caveats; the previous entry 'Results Submitted' appears to be removed.
    Difference
    1%
    Check dated 2025-12-09T18:59:38.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    A new revision entry v3.3.2 was added to the Record History, replacing the previous v3.2.0. No substantive changes to the study information are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:36:33.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Removed the general government funding/operating status notice from the page. The notice previously informed users about potential downtime and where to check for updates (opm.gov).
    Difference
    0.7%
    Check dated 2025-11-18T06:53:21.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    New version entry dated 2025-02-12 shows updated Recruitment Status and ongoing Study Status details in the record history. The change reflects current trial activity and availability information as recorded on ClinicalTrials.gov.
    Difference
    0.2%
    Check dated 2025-11-03T20:43:54.000Z thumbnail image

Stay in the know with updates to Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page.